Vantictumab Biosimilar (FZD Reference Antibody)
Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab is being studied against cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.
Product Specifications
Target
Vantictumab Biosimilar (Anti-FZD Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IRTAMSCD73TY23CBL100UG 100 µg
Anti Mouse CD73 Flow Cytometry Monoclonal Clone TY23 Biotin 100ug
Sign In for Pricing
View Details 